Search

everythinglearnresearchcommunity

for

Search:↓

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

These new skin treatments are safer and more effective with minimal side effects.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

Tridax procumbens extracts may help treat cancer due to their strong anticancer and antioxidant properties.

Pantethine may boost the immune system's ability to fight sarcoma.

Adding a second method to PROTACs could improve cancer treatment.

Tadalafil and Finasteride may help treat aggressive melanoma.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

The compound 4c showed strong potential as an anticancer agent.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Prostaglandins may protect hair follicles during chemotherapy.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.